Medical Condition News

RSS

AstraZeneca sponsorship to help support patient-centered programs in 35 hospitals

The American College of Cardiology is developing a program with support from founding sponsor AstraZeneca to provide personalized services to heart disease patients and help avoid a quick return to the hospital.

6 Jun 2013

BUSM researchers uncover important clues that may expand treatment options for schizophrenia

Researchers at Boston University School of Medicine have uncovered important clues about a biochemical pathway in the brain that may one day expand treatment options for schizophrenia.

6 Jun 2013

Governmental anti-obesity initiatives not successful, MU expert says

Americans are gaining weight at an alarming rate, with obesity increasing from 12 percent of the nation's population in 1990 to 23 percent by 2005, according to the Centers for Disease Control and Prevention.

6 Jun 2013

Research shows link between formula-feeding and higher risk for chronic diseases later in life

New evidence from research suggests that infants fed formula, rather than breast milk, experience metabolic stress that could play a part in the long-recognized link between formula-feeding and an increased risk of obesity, type 2 diabetes and other conditions in adult life.

6 Jun 2013

Scientists develop first dual-action drug against melanoma skin cancer cells

Scientists are reporting development and successful lab tests on the first potential drug to pack a lethal one-two punch against melanoma skin cancer cells. Hit number one destroys cells in the main tumor, and the second hit blocks the spread of the cancer to other sites in the body, according to their report in the journal ACS Chemical Biology.

6 Jun 2013

Women are 37% more likely to have COPD than men, says American Lung Association report

Women are 37 percent more likely to have chronic obstructive pulmonary disease (COPD) than men and now account for more than half of all deaths attributed to COPD in our nation.

6 Jun 2013

SLU research team awarded $1.4M to develop novel mechanical circulatory support device

A research team led by Theodosios Alexander, Sc. D., Dean of Parks College Engineering, Aviation and Technology at Saint Louis University, was awarded $1.4 million (GBP886k) by the Invention for Innovation (i4i) Program of the National Institute for Health Research to develop a novel mechanical circulatory support device.

6 Jun 2013

Vanda reports clinical data of tasimelteon Phase III studies for treatment of Non-24-Hour Disorder

Vanda Pharmaceuticals Inc. presented additional entrainment and patient-level clinical data at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies in Baltimore, from its SET (Safety and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study of the Efficacy and Safety of Tasimelteon to treat Non-24-Hour Disorder) Phase III studies of tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-24) in totally blind individuals.

6 Jun 2013

Accuray announces treatment of first patient with new TomoHDA System

Accuray Incorporated, announced today the first patient has been treated with its new TomoHDA System at Centre Oscar Lambret in Lille, France.

5 Jun 2013

Scientists discover protective role of retinoic acid against intestinal inflammation

Scientists at Trinity College Dublin have made novel discoveries around the protective influence of Vitamin A against the damaging immune responses that lead to inflammatory bowel disease.

5 Jun 2013

Does krill oil help your arthritis?

Arthritis is a condition that affects 1 in 5 Australians. That means that 1.4m people in NSW alone, have a form of arthritis and try to manage the impact it has on their lives. There are a number of very common and effective ways to tackle the condition such as physical activity and exercise, physical therapy, healthy eating and traditional medicines. All of these methods can play a role in reducing the pain arthritis causes in people’s daily lives.

5 Jun 2013

New approach in treating multiple sclerosis

In his article, "Pathoetiology of multiple sclerosis: are we barking up the wrong tree?", Peter K. Stys of the Hotchkiss Brain Institute, University of Calgary, argues that while the majority of the medical research community currently approaches MS as an autoimmune disease (much like Lupus and Rheumatoid Arthritis), for which the trigger is the immune system attacking a particular part of the nervous system, the features of the disease are equally well explained by approaching MS as a neurodegenerative disease (such as Parkinson's and Alzheimer's), which is followed by an immune reaction to damage.

5 Jun 2013

Doctors should conduct frail screening to prevent bad outcomes

Everyone older than 70 should be checked for frailty, a condition that is both easily treated and potentially deadly, according to an article by representatives from six major international and U.S. medical organizations.

5 Jun 2013

Low-dose ketamine anesthetic has potential to alleviate severe depression

Low-dose intravenous infusions of ketamine, a general anesthetic used in minor surgeries, given over a long period are an effective treatment for depression, Mayo Clinic researchers found. The study is published in the Journal of Psychopharmacology.

5 Jun 2013

Six top scientists studying psoriasis receive NPF research grants to discover new treatments for chronic diseases

Six of the top scientists studying psoriasis-the most common autoimmune disease in the country, affecting 7.5 million Americans-and psoriatic arthritis, an inflammatory joint and tendon disease affecting up to 30 percent of people with psoriasis, received National Psoriasis Foundation (NPF) research grants totaling $450,000 for projects that aim to discover new treatments and a cure for these chronic diseases.

5 Jun 2013

Study: Exposure to high altitude can cause acute mountain sickness, cerebral or pulmonary edema

"Exposure to high altitude can cause acute mountain sickness (AMS) and, in severe cases, cerebral or pulmonary edema. Capillary leakage has been hypothesized to play a role in the pathogenesis of AMS, although the mechanism of altitude-related illnesses remains largely unknown," writes Gabriel Willmann, M.D., of the University of Tubingen, Germany, and colleagues.

5 Jun 2013

Research: RG3039 drug can extend survival, improve function in spinal muscular atrophy mouse models

In a new publication that appears in Human Molecular Genetics, the laboratory of Christine DiDonato, PhD reports on their pharmacological characterization of the drug RG3039, demonstrating that it can extend survival and improve function in two spinal muscular atrophy (SMA) mouse models.

5 Jun 2013

EORTC BOS 2 trial to test efficacy of adding bevacizumab to peri-operative FOLFOX 4 chemotherapy

Colorectal cancer (CRC) is the second most frequent cause of cancer-related mortality in both Europe and the United States. Treatment for patients with resectable hepatic metastases from colorectal cancer consists of surgery combined with chemotherapy, but recurrence is observed in two thirds of these patients.

5 Jun 2013

Thomson Reuters announces this year's Hottest Researchers

The Intellectual Property & Science business of Thomson Reuters today announced this year's Hottest Researchers, a ranking of the most influential scientific researchers and research papers on ScienceWatch, the open web resource for science metrics and analysis.

5 Jun 2013

Study: Chronic exposure to rocket attacks increases adolescent violence

Chronic exposure to rocket attacks launched from the Gaza Strip into Israel is causing an increase in severe adolescent violence, according to a new study by Ben-Gurion University of the Negev (BGU) researchers.

5 Jun 2013

Medical Condition News

AstraZeneca sponsorship to help support patient-centered programs in 35 hospitals

BUSM researchers uncover important clues that may expand treatment options for schizophrenia

Governmental anti-obesity initiatives not successful, MU expert says

Research shows link between formula-feeding and higher risk for chronic diseases later in life

Scientists develop first dual-action drug against melanoma skin cancer cells

Women are 37% more likely to have COPD than men, says American Lung Association report

SLU research team awarded $1.4M to develop novel mechanical circulatory support device

Vanda reports clinical data of tasimelteon Phase III studies for treatment of Non-24-Hour Disorder

Accuray announces treatment of first patient with new TomoHDA System

Scientists discover protective role of retinoic acid against intestinal inflammation

Does krill oil help your arthritis?

New approach in treating multiple sclerosis

Doctors should conduct frail screening to prevent bad outcomes

Low-dose ketamine anesthetic has potential to alleviate severe depression

Six top scientists studying psoriasis receive NPF research grants to discover new treatments for chronic diseases

Study: Exposure to high altitude can cause acute mountain sickness, cerebral or pulmonary edema

Research: RG3039 drug can extend survival, improve function in spinal muscular atrophy mouse models

EORTC BOS 2 trial to test efficacy of adding bevacizumab to peri-operative FOLFOX 4 chemotherapy

Thomson Reuters announces this year's Hottest Researchers

Study: Chronic exposure to rocket attacks increases adolescent violence

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News